Generic Zolmitriptan

Zolmitriptan

Zolmitriptan is a selective serotonin 5‑HT1B/1D receptor agonist indicated for the acute treatment of migraine attacks with or without aura in adults. It works by constricting dilated intracranial blood vessels and inhibiting the release of pro‑inflammatory neuropeptides from trigeminal nerve endings, thereby relieving headache pain, nausea, photophobia, and phonophobia. Zolmitriptan is not used for migraine prophylaxis and should be taken at the first sign of a migraine attack. It is available as oral tablets, orally disintegrating tablets, and nasal spray. The 5 mg tablet is the highest oral strength and is used when lower doses provide insufficient relief.

Usual adult dose: The recommended starting dose is 2.5 mg taken orally at the onset of migraine symptoms. If the headache returns after initial relief, a second dose may be taken at least 2 hours after the first; the maximum single dose is 5 mg, and the maximum total daily dose is 10 mg. The 5 mg tablet is reserved for patients who do not achieve adequate relief with 2.5 mg and who tolerate the lower dose well. Zolmitriptan tablets should be swallowed whole with water and may be taken with or without food. The orally disintegrating tablet should be placed on the tongue and allowed to dissolve; no water is needed. If a patient does not respond to the first dose, a second dose for the same attack is unlikely to be effective. Treatment should be limited to no more than 3 days per week to avoid medication‑overuse headache. Zolmitriptan is contraindicated in patients with ischemic heart disease, coronary artery vasospasm, uncontrolled hypertension, or a history of stroke or transient ischemic attack.

Dosage form: Film‑coated tablets: 5 mg (pink, round, biconvex). Also available as 2.5 mg tablets and as orally disintegrating tablets in 2.5 mg and 5 mg strengths, as well as a nasal spray delivering 5 mg per actuation. The 5 mg oral tablet is the standard high‑strength formulation.

Onset of action: Pain relief typically begins within 30 to 60 minutes after oral administration, with peak effect at approximately 2 to 4 hours. A significant proportion of patients experience meaningful headache relief within 2 hours of dosing. The orally disintegrating tablet and nasal spray may have a slightly faster onset.

Duration of action: The therapeutic effect generally lasts for 2 to 4 hours, but recurrence of headache within 24 hours occurs in about 20% to 30% of patients; a second dose may be taken after 2 hours if needed. The elimination half‑life of zolmitriptan is approximately 3 hours.

Alcohol recommendation: Alcohol should be used with caution during zolmitriptan therapy. Alcohol can trigger or worsen migraine in some individuals and may increase the central nervous system depressant effects of zolmitriptan, causing drowsiness, dizziness, and impaired judgment. It is advisable to limit alcohol intake, especially during a migraine attack or within 24 hours of taking zolmitriptan.

Most common side effects: Tingling, numbness, warmth or flushing, dizziness, drowsiness, fatigue, and mild chest or throat tightness. These sensations are usually transient and not indicative of heart disease, but patients should seek immediate medical attention if chest pain, severe tightness, or pressure occurs. Other reported effects include nausea, dry mouth, and weakness. Zolmitriptan should not be used within 24 hours of ergotamine‑containing medications or other triptans due to the risk of additive vasoconstriction. It is contraindicated in patients with a history of myocardial infarction, Prinzmetal's angina, peripheral vascular disease, or severe hepatic impairment. In patients with risk factors for coronary artery disease, a cardiovascular evaluation is recommended before the first use. Zolmitriptan is available only by prescription in Canada and should be used under the guidance of a healthcare professional.

Would you like to try Zolmitriptan without a prescription?

Select doses
Select Package
Zolmitriptan
5 mg
x
1 bottle
$101.99
$ 84.99
$ 84.99 per bottle
save:  $0.00
Zolmitriptan
5 mg
x
2 bottles
$191.99
$ 159.99
$ 80.00 per bottle
save:  $9.98
Zolmitriptan
5 mg
x
3 bottles
$269.99
$ 224.99
$ 75.00 per bottle
save:  $29.97
Zolmitriptan
5 mg
x
4 bottles
$335.99
$ 279.99
$ 70.00 per bottle
save:  $59.96
Zolmitriptan
5 mg
x
5 bottles
$388.79
$ 323.99
$ 64.80 per bottle
save:  $100.95

Buy Generic Zolmitriptan () without prescription in Canada

At our pharmacy, you can buy Zolmitriptan without a prescription, with discreet and anonymous packaging delivered within 5-14 days across Canada.

What is Zolmitriptan?

Zolmitriptan is a medication used to treat migraine headaches. It belongs to a class of drugs called triptans, which work by narrowing blood vessels in the brain and blocking the release of chemicals that cause inflammation and pain during a migraine. This is not a painkiller that simply masks the ache. It interrupts the migraine process itself. A migraine involves dilation of blood vessels and activation of the trigeminal nerve. Zolmitriptan activates specific serotonin receptors, called 5-HT1B and 5-HT1D, on those blood vessels and nerve endings. That causes the blood vessels to constrict back to normal and stops the release of inflammatory neuropeptides. The migraine is cut off at the source.

Zolmitriptan is a rescue medication, not a preventive. You take it when you feel a migraine coming on. The effect begins within 30 to 60 minutes after taking the tablet. For many people, the headache is significantly reduced or gone within 2 hours. The 5 mg tablet is the higher oral strength. The standard starting dose is 2.5 mg, but the 5 mg dose is prescribed for those who need a stronger effect. Zolmitriptan is available as a generic and under the brand name Zomig. It comes as tablets and orally disintegrating tablets.

Mechanism and Pharmacology

Zolmitriptan is a selective agonist at 5-HT1B and 5-HT1D serotonin receptors. These receptors are found on the smooth muscle of intracranial blood vessels and on the nerve endings of the trigeminal system. During a migraine, these blood vessels dilate and become inflamed. The trigeminal nerve releases vasoactive peptides like calcitonin gene-related peptide (CGRP) and substance P. The combination of vasodilation and neurogenic inflammation causes the throbbing pain. Zolmitriptan binds to the 5-HT1B receptors on the blood vessels, causing them to constrict. It binds to the 5-HT1D receptors on the nerve endings, blocking the release of inflammatory peptides. This reduces both the vascular and neural components of the migraine.

After oral administration, zolmitriptan is well absorbed, with a bioavailability of about 40 percent. Peak plasma concentrations are reached in about 1 to 1.5 hours. Food does not significantly affect absorption. Zolmitriptan is metabolized in the liver by the enzyme CYP1A2, with a minor contribution from MAO-A. One of its metabolites, N-desmethylzolmitriptan, is also active. The half-life of zolmitriptan and its active metabolite is about 3 hours, longer than sumatriptan, giving a slightly longer duration of action. The drug is eliminated mainly in the urine as metabolites. In moderate to severe liver impairment, the dose should be reduced. Kidney impairment does not require dose adjustment for the oral form. The 5 mg dose provides a higher peak concentration and a more sustained effect than 2.5 mg.

How to Use Zolmitriptan

Take one 5 mg tablet as soon as you feel a migraine starting. The earlier you take it, the better it works. Swallow the tablet whole with water. You can take it with or without food. Do not crush or chew the tablet. If the headache returns after the first dose, you can take a second dose, but you must wait at least 2 hours after the first. Do not take more than 10 mg (two 5 mg tablets) in a 24-hour period. If the first dose does not help at all, do not take a second dose for the same attack. Discuss it with your doctor.

The 5 mg dose is usually prescribed after starting with 2.5 mg and finding it insufficient. Do not self-increase from 2.5 mg to 5 mg without medical advice, because the higher dose carries a greater risk of side effects. If you miss a dose, there is no schedule to miss. Zolmitriptan is taken as needed, not on a daily basis. Do not use it to prevent migraines. Using it more than 10 days per month can lead to medication-overuse headaches, also called rebound headaches. If you are using zolmitriptan more than 2 days per week, talk to your doctor about preventive treatment.

Side Effects of Zolmitriptan

The most common side effects are mild and transient. They include a feeling of tightness, pressure, or heaviness in the chest, neck, or jaw. This is called "triptan sensation" and is caused by the drug's effect on blood vessels. It is not a sign of heart damage. It usually passes within 15 to 30 minutes. Tingling, warmth, or a feeling of fullness in the face, arms, or legs is also common. Dizziness, drowsiness, and fatigue can occur. Some people feel nauseous, though this is often part of the migraine itself. A dry mouth or an unusual taste is possible. Because zolmitriptan is more lipophilic than sumatriptan, it crosses the blood-brain barrier more readily, which may cause slightly more central nervous system effects like sedation or a feeling of heaviness in the head.

More serious but rare side effects are related to excessive vasoconstriction. Zolmitriptan can cause coronary artery spasm, leading to chest pain, heart attack, or arrhythmias. This is why it is contraindicated in people with a history of heart disease, stroke, or uncontrolled high blood pressure. If you have new or unusual chest pain, shortness of breath, or pain spreading to your arm or jaw, seek emergency medical care immediately. This is not the typical triptan sensation that passes quickly. Zolmitriptan can also rarely cause severe allergic reactions, including anaphylaxis, with swelling of the face, lips, or throat, difficulty breathing, and hives. Serotonin syndrome can occur if zolmitriptan is combined with other serotonergic drugs, leading to agitation, confusion, sweating, and muscle twitching. This is also an emergency.

High-Risk Groups (Elderly, Pregnancy)

Pregnancy. Zolmitriptan is pregnancy category C. Animal studies have shown some adverse effects, but human data are limited. The Sumatriptan Pregnancy Registry and other data suggest that triptans as a class are not associated with a major increase in birth defects, but caution is advised. If you are pregnant or planning to become pregnant, discuss the use of zolmitriptan with your obstetrician and neurologist. Acetaminophen is usually the first choice in pregnancy, but if it doesn't work, a triptan may be considered after the first trimester. Breastfeeding. Zolmitriptan passes into breast milk in small amounts. The relative infant dose is low. The American Academy of Pediatrics considers triptans compatible with breastfeeding. To minimize exposure, the mother can take the dose immediately after nursing and wait 2 to 3 hours before the next feeding. Elderly patients can use zolmitriptan, but they are more likely to have cardiovascular disease, high blood pressure, and reduced liver or kidney function. A careful cardiac evaluation is essential before starting. Patients with severe liver impairment should use a lower dose. Zolmitriptan is contraindicated in people with ischemic heart disease, coronary artery spasm, peripheral vascular disease, uncontrolled hypertension, or a history of stroke or transient ischemic attack. It should not be used in patients with hemiplegic or basilar migraine.

Interaction With Activities (Driving, Alcohol)

Zolmitriptan can cause dizziness, drowsiness, and a feeling of heaviness. If you feel these effects, don't drive or operate machinery until they resolve. The sedation is usually mild and passes quickly. Alcohol has no direct interaction with zolmitriptan, but alcohol is a common migraine trigger and can worsen dehydration. It is best to avoid alcohol during a migraine attack. Heavy drinking is discouraged because it can increase the risk of liver strain and may worsen side effects like dizziness.

Drug Interactions

The most critical interaction is with monoamine oxidase inhibitors (MAOIs). Because zolmitriptan is partially metabolized by MAO-A, combining it with an MAOI can cause dangerously high levels, leading to severe vasoconstriction and hypertensive crisis. These drugs must be separated by at least 14 days. Other serotonergic drugs, including SSRIs, SNRIs, tricyclic antidepressants, and tramadol, can interact and cause serotonin syndrome. The combination should be used with caution and only if the benefit outweighs the risk. Ergot alkaloids, such as ergotamine and dihydroergotamine, cause vasoconstriction and are contraindicated when combined with zolmitriptan. The two should be separated by at least 24 hours. Other triptans should not be used together within 24 hours. St. John's Wort should be avoided. Cimetidine can inhibit CYP1A2 and increase zolmitriptan levels, though this is rarely a problem at usual doses. Always tell your doctor about every medication, supplement, and herbal product you take.

Alternative Options

Zolmitriptan is one of several triptans. Sumatriptan is the original and most studied. Rizatriptan and eletriptan have faster oral onset. Naratriptan and frovatriptan are slower but last longer and have fewer side effects. For those who cannot take triptans, other acute migraine treatments include NSAIDs like ibuprofen and naproxen, which work well for mild to moderate attacks. Acetaminophen is also used. For severe or refractory migraines, gepants like ubrogepant and rimegepant are newer oral CGRP receptor antagonists that do not cause vasoconstriction and are safe in patients with cardiovascular disease. Lasmiditan is a 5-HT1F agonist that also avoids vasoconstriction. For frequent migraines, preventive therapies like beta-blockers, topiramate, amitriptyline, or CGRP monoclonal antibodies may be used. The choice depends on the severity, cardiovascular risk, and previous response.

INN, Brand Names, and Classification in Canada

INN (International Nonproprietary Name): Zolmitriptan
Available brand names in Canada: Zomig, and generic zolmitriptan. Zomig Rapimelt is the orally disintegrating formulation.
ATC code: N02CC03
Forms and strengths: Tablets 2.5 mg and 5 mg; orally disintegrating tablets 2.5 mg and 5 mg; nasal spray 5 mg per actuation. The 5 mg tablet is the higher oral strength.
Manufacturers: AstraZeneca Canada Inc. (Zomig), and diverse generic manufacturers including Apotex Inc., Teva Canada Limited, and Sandoz Canada Inc.
Registration status in Canada: Registered
Classification: Prescription (Rx)

Frequently Asked Questions

Can I use Zolmitriptan every day?
No. Zolmitriptan is an acute treatment, not a preventive. Using it more than 10 days per month can cause medication-overuse headaches. If you need it more than 2 days per week, your doctor should consider preventive therapy.

What is the "triptan sensation" in my chest?
It is a feeling of tightness, pressure, or heaviness in the chest, neck, or jaw that occurs after taking zolmitriptan. It is caused by the drug's effect on blood vessels and is usually harmless, passing within 15 to 30 minutes. However, if the pain is severe, spreading to your arm or jaw, or accompanied by shortness of breath, it could be a heart problem and needs emergency care.

Can I take Zolmitriptan with ibuprofen?
Yes. Zolmitriptan and NSAIDs like ibuprofen work through different mechanisms and can be taken together for a migraine. The combination is often more effective than either alone. Always check with your doctor or pharmacist first, especially if you have stomach issues or kidney problems.

What if I take Zolmitriptan and the migraine comes back?
If the headache returns after the first dose, you can take a second dose, but you must wait at least 2 hours. Do not exceed 10 mg in 24 hours. If the migraine returns frequently, talk to your doctor about a longer-acting triptan like frovatriptan or naratriptan.

Can I use Zolmitriptan if I have high blood pressure?
Zolmitriptan is contraindicated in uncontrolled hypertension. If your blood pressure is well controlled on medication, your doctor may allow you to use it, but you need to be evaluated first. Never use it without a doctor's approval if you have any cardiovascular risk factors.

Delivery Information Across Canada

We ship Zolmitriptan to all provinces and territories. Delivery times vary depending on how remote your location is:

  • Ontario (Toronto, Ottawa, Mississauga): 5 to 7 days
  • Quebec (Montreal, Quebec City, Laval): 5 to 7 days
  • British Columbia (Vancouver, Victoria, Burnaby): 5 to 9 days
  • Alberta (Calgary, Edmonton, Red Deer): 5 to 9 days
  • Manitoba (Winnipeg, Brandon): 5 to 9 days
  • Saskatchewan (Saskatoon, Regina): 5 to 9 days
  • Nova Scotia (Halifax, Sydney): 5 to 9 days
  • New Brunswick (Moncton, Fredericton): 5 to 9 days
  • Newfoundland and Labrador (St. John's, Corner Brook): 7 to 14 days
  • Prince Edward Island (Charlottetown): 7 to 14 days
  • Yukon, Northwest Territories, Nunavut: 7 to 14 days

All shipments are packed discreetly with no branding or indication of contents on the outside.

There is no review for this product at the moment, but you can be the first to add or you can read more in Testimonials Page about related products.
Package Example
Front View
Side View
Back View
Your order will be packed safe and secure and dispatched within 24 hours. This is exactly how your parcel will look like (pictures of a real shipping item). It has a size and a look of a regular private letter (9.4x4.3x0.3 inches or 24x11x0.7cm) and it does not disclose its contents
Shipping method Delivery time Price  
Delivery 14-21 days 14.95$ Tracking# available in 4 days
Delivery 9-14 days 30$ Tracking# available in 2 days
  • Shipping worldwide
  • Confidentiality and anonymity guarantee
  • Safe and secure
  • Discrete looking packages
  • Dispatch orders within 24 hours
  • 100% success delivery